Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels-Reference-Cited by-同舟云学术

Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels

Published:2010-04-19 Issue:2 Volume:52 Page:454-461
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Rijckborst Vincent,Hansen Bettina E.,Cakaloglu Yilmaz,Ferenci Peter,Tabak Fehmi,Akdogan Meral,Simon Krzysztof,Akarca Ulus S.,Flisiak Robert,Verhey Elke,Van Vuuren Anneke J.,Boucher Charles A. B.,ter Borg Martijn J.,Janssen Harry L. A.

Publisher

Wiley

Subject

Hepatology

Reference35 articles.

1. Hepatitis B virus infection;Dienstag;N Engl J Med,2008

2. World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants;Funk;J Viral Hepat,2002

3. Hepatitis B e antigen-negative chronic hepatitis B;Hadziyannis;Hepatology,2001

4. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B;Lai;N Engl J Med,2006

5. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B;Marcellin;N Engl J Med,2008

Cited by 217 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HBV-miR-3 is closely related to HBV replication and strongly predictive of HBeAg seroconversion in PegIFN-α treated patients;Scientific Reports;2024-01-17

2. Clinical cure induced by pegylated interferon α-2b in the advantaged population of chronic hepatitis B virus infection: a retrospective cohort study;Frontiers in Cellular and Infection Microbiology;2024-01-16

3. Predictors of therapeutic response to peginterferon α‑2a and nucleos(t)ide analog combination therapy for HBeAg‑negative chronic hepatitis B: 1‑year follow‑up after treatment;Experimental and Therapeutic Medicine;2023-11-03

4. HBV-miR-3 is closely related to HBV replication and strongly predictive of HBeAg seroconversion in PegIFN-α treated patients;2023-09-12

5. Rapid monophasic HBsAg decline during nucleic-acid polymer–based therapy predicts functional cure;Hepatology Communications;2023-07-17